Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $8.48 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 42.14.
Market Cap
8.48T
Revenue
4.59T
Profits
201.33B
PE Ratio
42.14
Profit Margin
4.39%
Dividend Yield
0.42%
1057 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.01T | -0.31% | 3,150,187 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 567.53B | -2.12% | 7,485,372 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 391.49B | -2.70% | 5,155,744 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 373.43B | 1.23% | 6,633,585 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 283.88B | -3.45% | 15,071,968 | 65.77B |
| 6 | NVS | Novartis AG | 280.78B | -0.99% | 1,662,183 | 56.58B |
| 7 | AZN | AstraZeneca PLC | 275.12B | -0.84% | 1,323,450 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 197.15B | 0.06% | 10,064,560 | 50.57B |
| 9 | AMGN | Amgen Inc. | 189.21B | -1.30% | 4,305,357 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 176.13B | 0.98% | 1,711,325 | 45.20B |
| 11 | ABT | Abbott Laboratories | 154.41B | 0.53% | 10,385,501 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 154.28B | -1.06% | 6,490,585 | 29.74B |
| 13 | PFE | Pfizer Inc. | 148.27B | -0.74% | 34,015,555 | 63.32B |
| 14 | ISRG | Intuitive Surgical, Inc. | 147.50B | 1.32% | 2,566,186 | 10.58B |
| 15 | CVS | CVS Health Corporation | 128.49B | -1.23% | 7,369,778 | 405.62B |
| 16 | DHR | Danaher Corporation | 128.20B | 0.57% | 3,910,766 | 24.78B |
| 17 | SYK | Stryker Corporation | 118.02B | -1.39% | 2,430,016 | 25.27B |
| 18 | BMY | Bristol-Myers Squibb Company | 114.88B | -1.53% | 13,487,049 | 48.48B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 114.37B | 1.28% | 1,481,243 | 12.22B |
| 20 | SNY | Sanofi | 106.43B | -1.05% | 1,845,851 | 54.60B |
| 21 | GSK | GSK plc | 106.31B | -1.62% | 3,434,063 | 43.29B |
| 22 | MDT | Medtronic plc | 103.24B | 0.26% | 6,400,532 | 36.36B |
| 23 | MCK | McKesson Corporation | 91.30B | -0.54% | 823,576 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 87.14B | -0.70% | 659,011 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 86.57B | 0.79% | 1,800,152 | 76.39B |
| 26 | CI | The Cigna Group | 77.75B | -1.37% | 1,123,775 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 69.50B | -0.32% | 16,248,606 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 62.52B | 0.39% | 805,723 | 14.92B |
| 29 | ARGX | argenx SE | 54.92B | -1.04% | 297,772 | 4.74B |
| 30 | COR | Cencora, Inc. | 54.73B | -0.13% | 1,810,498 | 328.68B |
| 31 | CAH | Cardinal Health, Inc. | 53.02B | 1.13% | 2,368,103 | 250.74B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 50.18B | -0.85% | 2,090,910 | 28.34B |
| 33 | EW | Edwards Lifesciences Corporation | 49.65B | 1.30% | 2,889,148 | 6.30B |
| 34 | MDLN | Medline Inc. | 49.07B | 2.03% | 15,274,702 | 29.14B |
| 35 | HUM | Humana Inc. | 45.43B | -0.23% | 1,262,491 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.87B | 1.41% | 401,098 | 4.45B |
| 37 | BDX | Becton, Dickinson and Company | 40.09B | -0.50% | 1,719,410 | 22.23B |
| 38 | HLN | Haleon plc | 39.90B | -0.60% | 10,755,182 | 14.85B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 39.19B | -2.80% | 4,970,947 | 17.35B |
| 40 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.40B | 1.70% | 1,102,027 | 4.29B |
| 41 | A | Agilent Technologies, Inc. | 36.84B | 0.46% | 1,528,215 | 7.23B |
| 42 | WAT | Waters Corporation | 35.13B | 0.65% | 644,290 | 3.77B |
| 43 | RVMD | Revolution Medicines, Inc. | 34.00B | 3.94% | 2,129,513 | - |
| 44 | ZTS | Zoetis Inc. | 33.51B | 0.46% | 5,732,698 | 9.53B |
| 45 | ALC | Alcon Inc. | 32.57B | -0.90% | 1,838,018 | 10.63B |
| 46 | CNC | Centene Corporation | 31.31B | -2.73% | 6,429,334 | 178.33B |
| 47 | RPRX | Royalty Pharma plc | 31.25B | -1.09% | 1,933,090 | 2.44B |
| 48 | NTRA | Natera, Inc. | 30.97B | 1.97% | 868,306 | 2.50B |
| 49 | ONC | BeOne Medicines AG | 29.82B | 1.42% | 333,578 | 5.70B |
| 50 | IQV | IQVIA Holdings Inc. | 29.75B | -1.76% | 1,716,076 | 16.63B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 29.45B | -0.68% | 3,347,729 | 20.98B |
| 52 | BIIB | Biogen Inc. | 29.33B | -0.68% | 876,807 | 9.94B |
| 53 | DXCM | DexCom, Inc. | 28.63B | -1.55% | 5,374,308 | 4.82B |
| 54 | RMD | ResMed Inc. | 27.83B | -1.05% | 1,475,930 | 5.54B |
| 55 | VEEV | Veeva Systems Inc. | 26.36B | 1.71% | 2,282,201 | 3.32B |
| 56 | ILMN | Illumina, Inc. | 25.26B | 3.70% | 2,094,419 | 4.39B |
| 57 | PHG | Koninklijke Philips N.V. | 25.14B | 0.89% | 992,646 | 20.34B |
| 58 | MTD | Mettler-Toledo International Inc. | 23.35B | 2.13% | 203,396 | 4.09B |
| 59 | WST | West Pharmaceutical Services, Inc. | 23.32B | 0.37% | 423,583 | 3.22B |
| 60 | UTHR | United Therapeutics Corporation | 23.29B | 0.48% | 283,862 | 3.17B |
| 61 | BNTX | BioNTech SE | 22.95B | 0.25% | 824,262 | 3.23B |
| 62 | DGX | Quest Diagnostics Incorporated | 22.38B | -0.45% | 1,005,792 | 11.28B |
| 63 | LH | Labcorp Holdings Inc. | 21.72B | -0.48% | 460,887 | 14.14B |
| 64 | ROIV | Roivant Sciences Ltd. | 21.58B | -0.13% | 3,988,196 | 8.26M |
| 65 | INSM | Insmed Incorporated | 21.14B | -0.35% | 3,786,969 | 819.56M |
| 66 | MRNA | Moderna, Inc. | 20.68B | 4.45% | 6,315,837 | 2.23B |
| 67 | INCY | Incyte Corporation | 20.37B | -6.04% | 2,813,461 | 5.36B |
| 68 | STE | STERIS plc | 20.07B | -0.77% | 665,199 | 5.94B |
| 69 | VTRS | Viatris Inc. | 19.00B | -1.00% | 10,838,246 | 14.56B |
| 70 | GH | Guardant Health, Inc. | 17.22B | -1.36% | 1,648,942 | 1.08B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 17.05B | -0.50% | 1,525,445 | 8.41B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 16.02B | -0.29% | 1,242,196 | 3.10B |
| 73 | THC | Tenet Healthcare Corporation | 15.43B | 2.54% | 1,483,049 | 21.46B |
| 74 | GMAB | Genmab A/S | 15.19B | -2.01% | 1,022,981 | 3.90B |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 14.47B | 0.01% | 685,995 | 4.44B |
| 76 | ASND | Ascendis Pharma A/S | 13.88B | 2.47% | 622,460 | 998.25M |
| 77 | DVA | DaVita Inc. | 13.46B | 0.50% | 824,603 | 13.84B |
| 78 | BTSG | BrightSpring Health Services, Inc. | 13.35B | 1.32% | 2,533,029 | 13.65B |
| 79 | MEDP | Medpace Holdings, Inc. | 13.32B | -0.18% | 205,475 | 2.68B |
| 80 | EXEL | Exelixis, Inc. | 13.32B | -0.25% | 2,021,954 | 2.38B |
| 81 | BBIO | BridgeBio Pharma, Inc. | 13.32B | 1.81% | 3,072,235 | 579.96M |
| 82 | SOLV | Solventum Corporation | 13.30B | -2.62% | 1,318,664 | 8.26B |
| 83 | COO | The Cooper Companies, Inc. | 13.22B | -0.18% | 2,608,459 | 4.23B |
| 84 | AXSM | Axsome Therapeutics, Inc. | 13.04B | -0.71% | 623,523 | 708.24M |
| 85 | SNN | Smith & Nephew plc | 12.90B | -0.31% | 682,402 | 6.16B |
| 86 | ALGN | Align Technology, Inc. | 12.75B | 1.85% | 682,267 | 4.10B |
| 87 | FMS | Fresenius Medical Care AG | 12.68B | 1.87% | 730,382 | 22.32B |
| 88 | PEN | Penumbra, Inc. | 12.51B | -0.20% | 275,730 | 1.45B |
| 89 | IONS | Ionis Pharmaceuticals, Inc. | 12.23B | 0.96% | 1,506,272 | 1.06B |
| 90 | ELAN | Elanco Animal Health Incorporated | 12.13B | 0.48% | 4,471,049 | 4.89B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.50B | 3.72% | 283,575 | 1.13B |
| 92 | ICLR | ICON Public Limited Company | 11.30B | 1.00% | 598,032 | 8.25B |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 11.27B | 0.23% | 1,015,882 | 3.58B |
| 94 | RVTY | Revvity, Inc. | 11.21B | 0.85% | 933,409 | 2.90B |
| 95 | SMMT | Summit Therapeutics Inc. | 10.97B | 0.89% | 8,516,341 | - |
| 96 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.86B | 3.49% | 1,112,980 | 622.01M |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.76B | -0.54% | 1,425,968 | 3.24B |
| 98 | BAX | Baxter International Inc. | 10.75B | -0.22% | 5,970,445 | 11.32B |
| 99 | MOH | Molina Healthcare, Inc. | 10.51B | 0.77% | 862,478 | 43.10B |
| 100 | GMED | Globus Medical, Inc. | 10.49B | -3.88% | 1,651,626 | 3.10B |
| 101 | PODD | Insulet Corporation | 10.26B | -1.05% | 1,040,506 | 2.90B |
| 102 | EHC | Encompass Health Corporation | 9.85B | -2.10% | 1,000,495 | 6.07B |
| 103 | NUVL | Nuvalent, Inc. | 9.75B | 0.09% | 2,902,053 | - |
| 104 | CYTK | Cytokinetics, Incorporated | 9.68B | 1.60% | 989,780 | 105.82M |
| 105 | KRYS | Krystal Biotech, Inc. | 9.56B | 1.97% | 212,751 | 417.30M |
| 106 | TEM | Tempus AI, Inc. | 9.39B | 9.39% | 10,036,123 | 1.36B |
| 107 | HSIC | Henry Schein, Inc. | 9.24B | -0.22% | 1,157,376 | 13.38B |
| 108 | CRL | Charles River Laboratories International, Inc. | 9.08B | 0.52% | 690,221 | 4.03B |
| 109 | CORT | Corcept Therapeutics Incorporated | 8.91B | 0.16% | 877,140 | 769.10M |
| 110 | UHS | Universal Health Services, Inc. | 8.84B | -0.31% | 1,003,301 | 17.76B |
| 111 | TECH | Bio-Techne Corporation | 8.79B | 4.02% | 3,278,138 | 1.21B |
| 112 | OSCR | Oscar Health, Inc. | 8.78B | 3.18% | 6,149,082 | 13.30B |
| 113 | ENSG | The Ensign Group, Inc. | 8.73B | 0.84% | 680,934 | 5.27B |
| 114 | RGC | Regencell Bioscience Holdings Limited | 8.65B | -7.33% | 122,632 | - |
| 115 | BRKR | Bruker Corporation | 8.61B | 4.34% | 3,469,260 | 3.46B |
| 116 | HALO | Halozyme Therapeutics, Inc. | 8.45B | 2.53% | 1,799,633 | 1.51B |
| 117 | ABVX | ABIVAX Société Anonyme | 7.87B | 2.18% | 2,001,298 | 5.67M |
| 118 | BIO | Bio-Rad Laboratories, Inc. | 7.74B | 1.16% | 226,271 | 2.59B |
| 119 | QGEN | Qiagen N.V. | 7.65B | -0.16% | 2,450,874 | 2.10B |
| 120 | GKOS | Glaukos Corporation | 7.64B | 2.59% | 801,375 | 551.35M |
| 121 | ATR | AptarGroup, Inc. | 7.54B | 0.36% | 575,456 | 3.87B |
| 122 | IBRX | ImmunityBio, Inc. | 7.47B | 0.49% | 8,065,064 | 140.98M |
| 123 | ALKS | Alkermes plc | 7.39B | 0.08% | 1,804,127 | 1.56B |
| 124 | RGEN | Repligen Corporation | 7.38B | 0.21% | 632,685 | 763.34M |
| 125 | PRAX | Praxis Precision Medicines, Inc. | 7.35B | -1.16% | 374,652 | 7.46M |
| 126 | HQY | HealthEquity, Inc. | 7.27B | -1.56% | 1,234,588 | 1.34B |
| 127 | SYRE | Spyre Therapeutics, Inc. | 7.25B | 3.27% | 1,148,331 | - |
| 128 | PTGX | Protagonist Therapeutics, Inc. | 7.24B | 2.51% | 451,324 | 74.06M |
| 129 | PCVX | Vaxcyte, Inc. | 7.15B | 4.32% | 1,729,107 | - |
| 130 | TGTX | TG Therapeutics, Inc. | 7.13B | 1.55% | 2,574,131 | 700.35M |
| 131 | KYMR | Kymera Therapeutics, Inc. | 7.04B | -0.74% | 485,139 | 51.48M |
| 132 | HIMS | Hims & Hers Health, Inc. | 6.99B | 12.53% | 22,314,708 | 2.37B |
| 133 | IMVT | Immunovant, Inc. | 6.87B | -0.54% | 1,161,225 | - |
| 134 | LNTH | Lantheus Holdings, Inc. | 6.82B | 0.17% | 797,846 | 1.55B |
| 135 | AVTR | Avantor, Inc. | 6.64B | 3.57% | 8,342,318 | 6.55B |
| 136 | LEGN | Legend Biotech Corporation | 6.58B | -1.31% | 1,273,896 | 1.14B |
| 137 | APGE | Apogee Therapeutics, Inc. | 6.45B | -2.51% | 709,327 | - |
| 138 | GRFS | Grifols, S.A. | 6.45B | -0.20% | 378,026 | 8.58B |
| 139 | LQDA | Liquidia Corporation | 6.38B | 0.77% | 2,103,588 | 288.07M |
| 140 | PTCT | PTC Therapeutics, Inc. | 6.37B | 2.14% | 3,549,376 | 827.11M |
| 141 | MIRM | Mirum Pharmaceuticals, Inc. | 6.16B | 1.67% | 832,593 | 569.61M |
| 142 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.16B | 1.63% | 2,234,652 | 217.17M |
| 143 | CNTA | Centessa Pharmaceuticals plc | 6.15B | 0.08% | 1,409,114 | 15.00M |
| 144 | TFX | Teleflex Incorporated | 5.75B | -0.42% | 437,434 | 2.13B |
| 145 | PACS | PACS Group, Inc. | 5.75B | 0.17% | 1,060,374 | 5.43B |
| 146 | BLTE | Belite Bio, Inc | 5.68B | 4.53% | 237,698 | - |
| 147 | COGT | Cogent Biosciences, Inc. | 5.66B | 0.09% | 1,950,880 | - |
| 148 | CHE | Chemed Corporation | 5.61B | 1.12% | 289,305 | 2.54B |
| 149 | SRRK | Scholar Rock Holding Corporation | 5.49B | 3.69% | 801,373 | - |
| 150 | BLCO | Bausch + Lomb Corporation | 5.35B | -0.46% | 281,360 | 5.21B |
| 151 | HNGE | Hinge Health, Inc. | 5.29B | 4.58% | 1,870,290 | 646.34M |
| 152 | CGON | CG Oncology, Inc. | 5.25B | - | 909,005 | 5.07M |
| 153 | AMRX | Amneal Pharmaceuticals, Inc. | 5.18B | 0.25% | 2,314,031 | 3.05B |
| 154 | CAI | Caris Life Sciences, Inc. | 5.14B | 1.17% | 1,578,378 | 907.29M |
| 155 | LGND | Ligand Pharmaceuticals Incorporated | 5.12B | 0.01% | 119,246 | 274.48M |
| 156 | CRSP | CRISPR Therapeutics AG | 5.07B | 5.46% | 1,801,973 | 4.10M |
| 157 | XENE | Xenon Pharmaceuticals Inc. | 5.06B | 0.52% | 1,168,388 | 7.50M |
| 158 | TWST | Twist Bioscience Corporation | 5.03B | 6.14% | 2,642,095 | 409.48M |
| 159 | TVTX | Travere Therapeutics, Inc. | 5.00B | 3.38% | 2,105,873 | 536.20M |
| 160 | BLLN | BillionToOne, Inc. | 4.78B | 2.85% | 751,949 | 354.54M |
| 161 | TNGX | Tango Therapeutics, Inc. | 4.76B | 6.29% | 3,223,483 | 56.99M |
| 162 | SHC | Sotera Health Company | 4.63B | 0.25% | 1,780,091 | 1.19B |
| 163 | STVN | Stevanato Group S.p.A. | 4.54B | -2.63% | 561,081 | 1.39B |
| 164 | DNTH | Dianthus Therapeutics, Inc. | 4.51B | 0.49% | 764,490 | 1.34M |
| 165 | ERAS | Erasca, Inc. | 4.49B | 2.74% | 2,916,138 | - |
| 166 | RDNT | RadNet, Inc. | 4.48B | 0.46% | 840,825 | 2.14B |
| 167 | LIVN | LivaNova PLC | 4.38B | 0.33% | 755,255 | 1.43B |
| 168 | CELC | Celcuity Inc. | 4.30B | -0.35% | 1,112,666 | - |
| 169 | MMED | MiniMed Group, Inc. | 4.21B | -1.09% | 1,019,958 | 3.10B |
| 170 | ORKA | Oruka Therapeutics, Inc. | 4.16B | -1.34% | 1,002,319 | - |
| 171 | TXG | 10x Genomics, Inc. | 4.09B | 11.70% | 4,475,754 | 638.78M |
| 172 | ALHC | Alignment Healthcare, Inc. | 4.09B | 0.15% | 4,682,192 | 4.26B |
| 173 | MANE | Veradermics, Incorporated | 4.03B | 0.29% | 294,928 | - |
| 174 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.02B | 0.75% | 552,193 | 754.05M |
| 175 | NVST | Envista Holdings Corporation | 4.01B | 0.24% | 2,063,960 | 2.81B |
| 176 | MMSI | Merit Medical Systems, Inc. | 3.99B | 0.47% | 426,545 | 1.54B |
| 177 | VCYT | Veracyte, Inc. | 3.92B | 3.85% | 1,426,508 | 541.74M |
| 178 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | 0.02% | 2,807,122 | 596.96M |
| 179 | EWTX | Edgewise Therapeutics, Inc. | 3.79B | 1.03% | 926,726 | - |
| 180 | DOCS | Doximity, Inc. | 3.79B | 3.29% | 3,635,793 | 644.86M |
| 181 | IRTC | iRhythm Holdings, Inc. | 3.74B | 0.09% | 204,571 | 787.85M |
| 182 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.70B | 1.89% | 931,247 | 18.07M |
| 183 | ACAD | ACADIA Pharmaceuticals Inc. | 3.64B | 0.76% | 1,209,661 | 1.10B |
| 184 | CON | Concentra Group Holdings Parent, Inc. | 3.60B | 0.04% | 893,175 | 2.23B |
| 185 | ICUI | ICU Medical, Inc. | 3.59B | 1.09% | 158,479 | 2.16B |
| 186 | NAMS | NewAmsterdam Pharma Company N.V. | 3.57B | 0.56% | 648,048 | 22.57M |
| 187 | WAY | Waystar Holding Corp. | 3.55B | -1.17% | 1,709,538 | 1.16B |
| 188 | OGN | Organon & Co. | 3.53B | 0.11% | 2,120,054 | 6.16B |
| 189 | DNLI | Denali Therapeutics Inc. | 3.52B | 2.35% | 1,386,085 | - |
| 190 | HAE | Haemonetics Corporation | 3.50B | -1.65% | 885,923 | 1.33B |
| 191 | VKTX | Viking Therapeutics, Inc. | 3.44B | 2.92% | 1,015,305 | - |
| 192 | LFST | LifeStance Health Group, Inc. | 3.34B | 1.18% | 2,211,036 | 1.49B |
| 193 | OPCH | Option Care Health, Inc. | 3.33B | 2.19% | 3,986,104 | 5.67B |
| 194 | TLX | Telix Pharmaceuticals Limited | 3.30B | -0.21% | 294,210 | 803.79M |
| 195 | RLAY | Relay Therapeutics, Inc. | 3.26B | 1.08% | 1,879,444 | 10.68M |
| 196 | BKD | Brookdale Senior Living Inc. | 3.25B | 1.41% | 5,096,609 | 3.00B |
| 197 | WRBY | Warby Parker Inc. | 3.24B | -0.26% | 3,062,995 | 890.57M |
| 198 | PBLS | Parabilis Medicines, Inc. | 3.23B | -7.08% | 1,278,674 | - |
| 199 | ARQT | Arcutis Biotherapeutics, Inc. | 3.20B | 5.00% | 1,784,527 | 415.62M |
| 200 | DYN | Dyne Therapeutics, Inc. | 3.10B | 3.22% | 1,643,536 | - |
| 201 | BEAM | Beam Therapeutics Inc. | 3.09B | 7.10% | 2,636,280 | 164.01M |
| 202 | ITGR | Integer Holdings Corporation | 3.09B | -0.05% | 140,446 | 1.86B |
| 203 | GPCR | Structure Therapeutics Inc. | 3.06B | 0.42% | 633,691 | - |
| 204 | NHC | National HealthCare Corporation | 3.06B | -1.04% | 121,766 | 1.53B |
| 205 | RCUS | Arcus Biosciences, Inc. | 3.04B | 1.55% | 1,218,642 | 236.00M |
| 206 | ALMS | Alumis Inc. | 2.93B | -4.89% | 1,557,660 | 8.40M |
| 207 | PRVA | Privia Health Group, Inc. | 2.90B | -1.84% | 1,170,839 | 2.25B |
| 208 | HTFL | HeartFlow, Inc. | 2.83B | -1.20% | 1,120,436 | 191.42M |
| 209 | ADPT | Adaptive Biotechnologies Corporation | 2.79B | -0.88% | 2,805,154 | 295.41M |
| 210 | GRDN | Guardian Pharmacy Services, Inc. | 2.72B | -0.37% | 221,474 | 1.46B |
| 211 | IRON | Disc Medicine, Inc. | 2.68B | 3.00% | 464,050 | - |
| 212 | IDYA | IDEAYA Biosciences, Inc. | 2.65B | 4.18% | 1,247,463 | 225.27M |
| 213 | TARS | Tarsus Pharmaceuticals, Inc. | 2.65B | -0.52% | 381,320 | 535.08M |
| 214 | TMDX | TransMedics Group, Inc. | 2.61B | 3.57% | 947,282 | 635.89M |
| 215 | DFTX | Definium Therapeutics, Inc. | 2.59B | -3.96% | 1,231,953 | - |
| 216 | ELVN | Enliven Therapeutics, Inc. | 2.58B | -8.17% | 2,790,227 | - |
| 217 | GRAL | GRAIL, Inc. | 2.56B | -0.18% | 643,780 | 156.12M |
| 218 | KLRA | Kailera Therapeutics, Inc. | 2.54B | 3.92% | 367,138 | - |
| 219 | SUPN | Supernus Pharmaceuticals, Inc. | 2.54B | -1.38% | 901,382 | 776.83M |
| 220 | CLOV | Clover Health Investments, Corp. | 2.53B | 1.48% | 7,092,424 | 2.21B |
| 221 | CLDX | Celldex Therapeutics, Inc. | 2.52B | 2.65% | 1,003,901 | 865.00K |
| 222 | RARE | Ultragenyx Pharmaceutical Inc. | 2.49B | 4.19% | 1,478,667 | 670.00M |
| 223 | ESTA | Establishment Labs Holdings Inc. | 2.48B | 2.41% | 449,495 | 229.58M |
| 224 | VERA | Vera Therapeutics, Inc. | 2.45B | -0.35% | 461,697 | - |
| 225 | AXGN | Axogen, Inc. | 2.33B | 1.79% | 2,882,118 | 238.11M |
| 226 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.30B | 4.14% | 3,989,158 | 885.72M |
| 227 | ACHC | Acadia Healthcare Company, Inc. | 2.30B | 1.52% | 2,071,025 | 3.37B |
| 228 | PBH | Prestige Consumer Healthcare Inc. | 2.21B | -2.30% | 726,068 | 1.09B |
| 229 | PHVS | Pharvaris N.V. | 2.18B | 1.76% | 103,106 | - |
| 230 | KOD | Kodiak Sciences Inc. | 2.13B | 0.21% | 439,961 | - |
| 231 | PGNY | Progyny, Inc. | 2.10B | 0.84% | 1,373,026 | 1.29B |
| 232 | LMAT | LeMaitre Vascular, Inc. | 2.10B | -0.27% | 207,988 | 256.28M |
| 233 | TRVI | Trevi Therapeutics, Inc. | 2.08B | 3.31% | 1,350,665 | - |
| 234 | NTLA | Intellia Therapeutics, Inc. | 2.08B | 23.16% | 16,279,696 | 66.09M |
| 235 | NKTR | Nektar Therapeutics | 2.07B | 3.02% | 667,016 | 55.63M |
| 236 | SEM | Select Medical Holdings Corporation | 2.06B | -0.09% | 1,223,553 | 5.52B |
| 237 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | 1.14% | 1,093,019 | 298.30M |
| 238 | IMNM | Immunome, Inc. | 2.05B | -1.69% | 905,108 | 4.02M |
| 239 | NVCR | NovoCure Limited | 2.04B | -1.10% | 2,033,510 | 674.41M |
| 240 | XRAY | DENTSPLY SIRONA Inc. | 2.03B | 0.40% | 2,918,785 | 3.68B |
| 241 | NEOG | Neogen Corporation | 2.02B | 2.20% | 1,241,823 | 870.56M |
| 242 | ZLAB | Zai Lab Limited | 1.99B | 3.78% | 637,961 | 453.28M |
| 243 | HRMY | Harmony Biosciences Holdings, Inc. | 1.98B | -0.73% | 985,786 | 899.11M |
| 244 | MLYS | Mineralys Therapeutics, Inc. | 1.97B | 1.31% | 1,758,275 | - |
| 245 | ADMA | ADMA Biologics, Inc. | 1.97B | 3.47% | 4,512,493 | 509.86M |
| 246 | OCUL | Ocular Therapeutix, Inc. | 1.97B | 0.50% | 2,467,140 | 52.04M |
| 247 | SGRY | Surgery Partners, Inc. | 1.96B | -1.24% | 1,794,016 | 3.34B |
| 248 | MD | Pediatrix Medical Group, Inc. | 1.95B | 0.31% | 615,076 | 1.93B |
| 249 | VCEL | Vericel Corporation | 1.95B | 1.98% | 476,551 | 292.09M |
| 250 | LKFT | Lakefront Biotherapeutics NV | 1.90B | -1.04% | 372,459 | 1.20B |
| 251 | ASTH | Astrana Health, Inc. | 1.90B | -0.66% | 387,104 | 3.53B |
| 252 | AGL | agilon health, inc. | 1.90B | 0.91% | 282,395 | 5.82B |
| 253 | AGIO | Agios Pharmaceuticals, Inc. | 1.89B | 7.94% | 1,650,835 | 66.05M |
| 254 | STOK | Stoke Therapeutics, Inc. | 1.86B | 0.34% | 429,734 | 32.08M |
| 255 | BHC | Bausch Health Companies Inc. | 1.86B | -1.58% | 2,289,671 | 10.53B |
| 256 | MBX | MBX Biosciences, Inc. | 1.85B | 9.74% | 1,165,463 | - |
| 257 | HCM | HUTCHMED (China) Limited | 1.85B | -0.82% | 22,208 | 548.51M |
| 258 | BHVN | Biohaven Ltd. | 1.83B | 7.93% | 4,469,495 | - |
| 259 | RAPP | Rapport Therapeutics, Inc. | 1.82B | -0.81% | 253,168 | 20.00M |
| 260 | OMCL | Omnicell, Inc. | 1.82B | 5.66% | 922,257 | 1.23B |
| 261 | WGS | GeneDx Holdings Corp. | 1.81B | 1.92% | 979,396 | 442.68M |
| 262 | UFPT | UFP Technologies, Inc. | 1.81B | -0.27% | 158,113 | 608.85M |
| 263 | IOVA | Iovance Biotherapeutics, Inc. | 1.80B | -1.23% | 12,629,205 | 285.61M |
| 264 | VRDN | Viridian Therapeutics, Inc. | 1.80B | -0.37% | 1,705,976 | 70.92M |
| 265 | NBTX | Nanobiotix S.A. | 1.80B | 4.39% | 116,444 | 38.27M |
| 266 | MESO | Mesoblast Limited | 1.79B | -1.01% | 118,552 | 65.38M |
| 267 | PLSE | Pulse Biosciences, Inc. | 1.79B | 6.03% | 362,535 | 751.00K |
| 268 | NUVB | Nuvation Bio Inc. | 1.79B | 4.37% | 4,180,343 | 143.05M |
| 269 | NRIX | Nurix Therapeutics, Inc. | 1.76B | 0.41% | 2,681,457 | 71.78M |
| 270 | QURE | uniQure N.V. | 1.76B | 1.02% | 993,161 | 18.09M |
| 271 | ANIP | ANI Pharmaceuticals, Inc. | 1.74B | 0.71% | 284,519 | 923.71M |
| 272 | RXRX | Recursion Pharmaceuticals, Inc. | 1.74B | 4.29% | 15,275,198 | 66.41M |
| 273 | GENB | Generate Biomedicines, Inc. | 1.74B | 9.61% | 567,625 | 30.30M |
| 274 | ANAB | AnaptysBio, Inc. | 1.73B | 5.89% | 668,420 | 232.39M |
| 275 | ADUS | Addus HomeCare Corporation | 1.72B | 1.10% | 224,247 | 1.45B |
| 276 | TSHA | Taysha Gene Therapies, Inc. | 1.72B | 4.64% | 4,632,177 | 7.47M |
| 277 | PGEN | Precigen, Inc. | 1.71B | 7.75% | 6,751,176 | 31.60M |
| 278 | TYRA | Tyra Biosciences, Inc. | 1.70B | 5.69% | 987,113 | - |
| 279 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.69B | 4.18% | 2,897,146 | -665.00K |
| 280 | ZYME | Zymeworks Inc. | 1.68B | 0.81% | 474,795 | 81.26M |
| 281 | PVLA | Palvella Therapeutics, Inc. | 1.67B | 6.99% | 265,085 | - |
| 282 | SRPT | Sarepta Therapeutics, Inc. | 1.67B | 3.04% | 2,307,279 | 2.18B |
| 283 | INVA | Innoviva, Inc. | 1.65B | -1.72% | 709,835 | 420.69M |
| 284 | SNDX | Syndax Pharmaceuticals, Inc. | 1.64B | 1.12% | 1,923,543 | 217.17M |
| 285 | SEPN | Septerna, Inc. | 1.63B | 0.39% | 287,760 | 72.26M |
| 286 | SION | Sionna Therapeutics, Inc. | 1.62B | 0.08% | 249,759 | - |
| 287 | SNDA | Sonida Senior Living, Inc. | 1.61B | -1.40% | 591,874 | 367.34M |
| 288 | AAPG | Ascentage Pharma Group International | 1.61B | -0.45% | 11,431 | 82.08M |
| 289 | ABCL | AbCellera Biologics Inc. | 1.60B | 0.29% | 3,678,418 | 79.21M |
| 290 | CMPS | COMPASS Pathways plc | 1.59B | -2.36% | 2,067,330 | - |
| 291 | FTRE | Fortrea Holdings Inc. | 1.58B | 1.03% | 948,701 | 2.71B |
| 292 | AVAH | Aveanna Healthcare Holdings Inc. | 1.57B | 1.90% | 1,256,587 | 2.52B |
| 293 | CAPR | Capricor Therapeutics, Inc. | 1.54B | 3.26% | 985,485 | 11.13M |
| 294 | GLUE | Monte Rosa Therapeutics, Inc. | 1.53B | -0.74% | 654,852 | 42.95M |
| 295 | HCSG | Healthcare Services Group, Inc. | 1.53B | -0.65% | 487,284 | 1.85B |
| 296 | NVAX | Novavax, Inc. | 1.52B | 3.89% | 3,563,299 | 596.34M |
| 297 | URGN | UroGen Pharma Ltd. | 1.50B | 3.84% | 781,189 | 140.49M |
| 298 | PRGO | Perrigo Company plc | 1.48B | -2.68% | 2,724,675 | 4.18B |
| 299 | BFLY | Butterfly Network, Inc. | 1.47B | 1.53% | 6,453,068 | 102.92M |
| 300 | IMCR | Immunocore Holdings plc | 1.45B | -1.48% | 209,244 | 412.81M |
| 301 | HROW | Harrow, Inc. | 1.45B | 3.36% | 608,678 | 268.68M |
| 302 | VIR | Vir Biotechnology, Inc. | 1.45B | -0.35% | 1,393,179 | 65.50M |
| 303 | NEO | NeoGenomics, Inc. | 1.44B | -0.54% | 816,925 | 745.97M |
| 304 | ALMR | Alamar Biosciences, Inc. | 1.44B | -5.55% | 156,129 | 87.16M |
| 305 | SLS | SELLAS Life Sciences Group, Inc. | 1.44B | -1.47% | 5,805,508 | - |
| 306 | BCAX | Bicara Therapeutics Inc. | 1.42B | -0.55% | 375,448 | - |
| 307 | MLTX | MoonLake Immunotherapeutics | 1.41B | 2.78% | 575,652 | - |
| 308 | ATAI | AtaiBeckley Inc. | 1.41B | -2.04% | 3,336,278 | 3.49M |
| 309 | ATRC | AtriCure, Inc. | 1.41B | -3.06% | 661,643 | 552.16M |
| 310 | STAA | STAAR Surgical Company | 1.41B | -0.16% | 317,725 | 290.38M |
| 311 | AVBP | ArriVent BioPharma, Inc. | 1.41B | -1.18% | 352,606 | - |
| 312 | ARDX | Ardelyx, Inc. | 1.40B | -0.18% | 3,098,843 | 427.68M |
| 313 | GHRS | GH Research PLC | 1.39B | -3.88% | 145,343 | - |
| 314 | INBX | Inhibrx Biosciences, Inc. | 1.37B | 1.19% | 380,105 | 1.30M |
| 315 | IART | Integra LifeSciences Holdings Corporation | 1.36B | -1.80% | 891,529 | 1.64B |
| 316 | ARDT | Ardent Health, Inc. | 1.36B | 1.28% | 739,330 | 6.43B |
| 317 | SVRA | Savara Inc. | 1.35B | 1.14% | 1,287,713 | - |
| 318 | TDOC | Teladoc Health, Inc. | 1.35B | 1.70% | 3,786,857 | 2.51B |
| 319 | MAZE | Maze Therapeutics, Inc. | 1.34B | 0.67% | 635,327 | 20.00M |
| 320 | AHCO | AdaptHealth Corp. | 1.33B | -1.92% | 1,212,605 | 3.29B |
| 321 | PRCT | PROCEPT BioRobotics Corporation | 1.32B | -9.69% | 3,198,766 | 322.02M |
| 322 | ALVO | Alvotech | 1.32B | 1.44% | 598,896 | 562.04M |
| 323 | PAHC | Phibro Animal Health Corporation | 1.31B | 2.54% | 208,640 | 1.50B |
| 324 | BLFS | BioLife Solutions, Inc. | 1.30B | 2.03% | 829,244 | 101.66M |
| 325 | IMTX | Immatics N.V. | 1.29B | 0.59% | 160,156 | 43.00M |
| 326 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.28B | -0.70% | 2,915,915 | 204.73M |
| 327 | ATEC | Alphatec Holdings, Inc. | 1.27B | 0.06% | 3,824,483 | 787.08M |
| 328 | MPLT | MapLight Therapeutics, Inc. | 1.24B | -1.14% | 168,252 | - |
| 329 | CDNA | CareDx, Inc. | 1.24B | 4.79% | 903,379 | 412.82M |
| 330 | INNV | InnovAge Holding Corp. | 1.24B | 0.38% | 331,325 | 949.17M |
| 331 | MNKD | MannKind Corporation | 1.23B | 9.02% | 5,586,445 | 360.78M |
| 332 | DMRA | Damora Therapeutics, Inc. | 1.23B | -3.66% | 590,607 | - |
| 333 | AVLN | Avalyn Pharma Inc. | 1.21B | -3.59% | 250,356 | - |
| 334 | ENOV | Enovis Corporation | 1.20B | -4.17% | 845,442 | 2.28B |
| 335 | AMN | AMN Healthcare Services, Inc. | 1.20B | 0.26% | 1,229,232 | 3.42B |
| 336 | XERS | Xeris Biopharma Holdings, Inc. | 1.19B | 1.33% | 2,134,053 | 314.85M |
| 337 | KMTS | Kestra Medical Technologies, Ltd. | 1.19B | -2.54% | 267,404 | 83.72M |
| 338 | INSP | Inspire Medical Systems, Inc. | 1.18B | -3.75% | 1,040,730 | 915.25M |
| 339 | ZBIO | Zenas BioPharma, Inc. | 1.18B | -5.56% | 510,795 | 10.00M |
| 340 | AVNS | Avanos Medical, Inc. | 1.17B | 0.06% | 532,910 | 715.90M |
| 341 | IRMD | IRADIMED CORPORATION | 1.16B | -3.16% | 158,204 | 86.28M |
| 342 | WVE | Wave Life Sciences Ltd. | 1.15B | 1.87% | 2,320,182 | 71.80M |
| 343 | PNTG | The Pennant Group, Inc. | 1.15B | 0.55% | 196,615 | 1.02B |
| 344 | TNDM | Tandem Diabetes Care, Inc. | 1.15B | 0.90% | 1,635,069 | 1.03B |
| 345 | AKTS | Aktis Oncology, Inc. | 1.15B | -5.52% | 487,196 | 8.28M |
| 346 | ABSI | Absci Corporation | 1.13B | 6.91% | 6,670,011 | 1.84M |
| 347 | AHG | Akso Health Group | 1.11B | -2.99% | 11,289 | 14.84M |
| 348 | COLL | Collegium Pharmaceutical, Inc. | 1.11B | -1.30% | 336,423 | 796.33M |
| 349 | COAG | Hemab Therapeutics Holdings, Inc. | 1.10B | 0.08% | 191,825 | - |
| 350 | DBVT | DBV Technologies S.A. | 1.09B | 2.78% | 170,960 | 5.74M |
| 351 | SDGR | Schrödinger, Inc. | 1.09B | 1.11% | 1,045,834 | 254.91M |
| 352 | OPK | OPKO Health, Inc. | 1.06B | -1.06% | 2,596,356 | 581.12M |
| 353 | AZTA | Azenta, Inc. | 1.06B | 1.51% | 694,996 | 596.48M |
| 354 | OMDA | Omada Health, Inc. | 1.03B | 0.99% | 901,200 | 283.30M |
| 355 | CNMD | CONMED Corporation | 1.03B | -1.90% | 619,025 | 1.37B |
| 356 | PSNL | Personalis, Inc. | 1.03B | 2.14% | 2,518,266 | 64.52M |
| 357 | AORT | Artivion, Inc. | 1.02B | 4.85% | 1,059,358 | 458.69M |
| 358 | NUTX | Nutex Health Inc. | 1.02B | 2.85% | 70,540 | 879.95M |
| 359 | EYPT | EyePoint, Inc. | 1.01B | -7.29% | 1,081,525 | 7.61M |
| 360 | CRON | Cronos Group Inc. | 1.01B | -1.68% | 992,371 | 159.54M |
| 361 | CRVS | Corvus Pharmaceuticals, Inc. | 1.00B | -0.25% | 519,611 | - |
| 362 | USPH | U.S. Physical Therapy, Inc. | 994.85M | -0.29% | 262,778 | 787.69M |
| 363 | QDEL | QuidelOrtho Corporation | 992.18M | 2.97% | 1,338,066 | 2.66B |
| 364 | EVO | Evotec SE | 981.25M | 3.31% | 34,572 | 859.03M |
| 365 | SPRY | ARS Pharmaceuticals, Inc. | 974.66M | 0.56% | 1,049,007 | 98.99M |
| 366 | JBIO | Jade Biosciences, Inc. | 955.69M | 4.95% | 1,295,457 | - |
| 367 | SPTX | Seaport Therapeutics, Inc. | 929.58M | -2.61% | 98,081 | - |
| 368 | GDRX | GoodRx Holdings, Inc. | 926.28M | 3.21% | 1,158,872 | 787.89M |
| 369 | PHAR | Pharming Group N.V. | 909.55M | 0.12% | 3,554 | 369.49M |
| 370 | AVR | Anteris Technologies Global Corp. | 906.68M | 2.95% | 854,933 | 1.85M |
| 371 | LMRI | Lumexa Imaging Holdings, Inc. | 902.20M | -2.59% | 784,073 | 1.03B |
| 372 | XNCR | Xencor, Inc. | 901.19M | -1.42% | 518,915 | 97.36M |
| 373 | MGTX | MeiraGTx Holdings plc | 900.63M | 1.41% | 633,098 | 79.76M |
| 374 | PCRX | Pacira BioSciences, Inc. | 893.59M | -1.22% | 349,382 | 734.86M |
| 375 | BIOA | BioAge Labs, Inc. | 884.61M | 10.31% | 744,701 | 10.32M |
| 376 | ETON | Eton Pharmaceuticals, Inc. | 880.39M | 1.74% | 263,124 | 86.93M |
| 377 | TALK | Talkspace, Inc. | 871.90M | -0.10% | 2,704,590 | 238.37M |
| 378 | DRTS | Alpha Tau Medical Ltd. | 871.10M | -1.93% | 638,322 | - |
| 379 | LXRX | Lexicon Pharmaceuticals, Inc. | 870.62M | 2.08% | 2,080,291 | 69.64M |
| 380 | AMPH | Amphastar Pharmaceuticals, Inc. | 869.51M | -1.84% | 454,903 | 720.53M |
| 381 | ORIC | ORIC Pharmaceuticals, Inc. | 869.03M | 1.51% | 1,225,293 | - |
| 382 | OLMA | Olema Pharmaceuticals, Inc. | 862.56M | 0.05% | 1,319,602 | - |
| 383 | INMD | InMode Ltd. | 858.83M | 0.78% | 664,204 | 374.64M |
| 384 | SANA | Sana Biotechnology, Inc. | 854.71M | 6.34% | 2,780,717 | - |
| 385 | ABUS | Arbutus Biopharma Corporation | 853.36M | 1.41% | 931,218 | 191.45M |
| 386 | PHAT | Phathom Pharmaceuticals, Inc. | 850.30M | 3.23% | 691,936 | 204.89M |
| 387 | KURA | Kura Oncology, Inc. | 843.80M | 5.03% | 1,680,356 | 71.64M |
| 388 | TBPH | Theravance Biopharma, Inc. | 842.38M | -1.80% | 346,348 | 109.78M |
| 389 | JANX | Janux Therapeutics, Inc. | 837.32M | 1.25% | 573,944 | 13.73M |
| 390 | ODTX | Odyssey Therapeutics, Inc. | 836.87M | 4.97% | 269,050 | 2.98M |
| 391 | CGEM | Cullinan Therapeutics, Inc. | 836.44M | -0.66% | 1,790,012 | - |
| 392 | IVA | Inventiva S.A. | 822.46M | -2.73% | 350,663 | 7.94M |
| 393 | LBRX | LB Pharmaceuticals Inc | 818.00M | 0.37% | 201,796 | - |
| 394 | ESPR | Esperion Therapeutics, Inc. | 813.48M | 0.32% | 8,804,179 | 418.24M |
| 395 | CERT | Certara, Inc. | 808.94M | - | 2,774,490 | 419.75M |
| 396 | AVTX | Avalo Therapeutics, Inc. | 767.46M | -1.08% | 865,241 | 59.00K |
| 397 | VOR | Vor Biopharma Inc. | 759.42M | -2.40% | 1,817,734 | - |
| 398 | ANNX | Annexon, Inc. | 759.41M | -1.59% | 2,898,042 | - |
| 399 | HSTM | HealthStream, Inc. | 756.09M | -0.96% | 117,266 | 311.78M |
| 400 | EVMN | Evommune, Inc. | 749.18M | 4.89% | 447,551 | 10.00M |
| 401 | NNNN | Anbio Biotechnology | 745.71M | 8.98% | 17,374 | 8.65M |
| 402 | ANRO | Alto Neuroscience, Inc. | 743.99M | -1.26% | 200,607 | - |
| 403 | ZVRA | Zevra Therapeutics, Inc. | 741.30M | -0.87% | 1,870,456 | 122.29M |
| 404 | GERN | Geron Corporation | 740.96M | 0.43% | 9,815,971 | 196.12M |
| 405 | REPL | Replimune Group, Inc. | 738.20M | 0.68% | 1,970,572 | - |
| 406 | SLDB | Solid Biosciences Inc. | 720.65M | 2.52% | 2,064,034 | - |
| 407 | BVS | Bioventus Inc. | 718.40M | 1.06% | 631,919 | 576.30M |
| 408 | AURA | Aura Biosciences, Inc. | 708.67M | 0.23% | 581,765 | - |
| 409 | SSII | SS Innovations International, Inc. | 706.46M | 5.06% | 91,444 | 48.47M |
| 410 | CBLL | CeriBell, Inc. | 702.70M | 0.27% | 203,463 | 95.07M |
| 411 | OCS | Oculis Holding AG | 701.71M | 4.78% | 739,772 | 1.40M |
| 412 | DSGN | Design Therapeutics, Inc. | 696.40M | 1.64% | 822,422 | - |
| 413 | TENX | Tenax Therapeutics, Inc. | 678.87M | 0.44% | 759,630 | - |
| 414 | CRMD | CorMedix Inc. | 675.08M | -1.54% | 1,411,374 | 400.05M |
| 415 | OMER | Omeros Corporation | 673.45M | 6.53% | 1,942,156 | 9.89M |
| 416 | SIBN | SI-BONE, Inc. | 671.89M | -1.75% | 649,296 | 206.22M |
| 417 | ALLO | Allogene Therapeutics, Inc. | 671.33M | 2.37% | 5,271,692 | 22.00K |
| 418 | RLMD | Relmada Therapeutics, Inc. | 667.63M | -4.29% | 3,074,661 | - |
| 419 | CTMX | CytomX Therapeutics, Inc. | 660.73M | 0.83% | 2,919,606 | 35.54M |
| 420 | GMRS | GMR Solutions Inc. | 647.60M | -2.91% | 646,155 | 5.83B |
| 421 | BBNX | Beta Bionics, Inc. | 640.80M | -1.03% | 442,535 | 110.24M |
| 422 | SGP | SpyGlass Pharma, Inc. | 630.42M | 2.28% | 143,812 | - |
| 423 | CADL | Candel Therapeutics, Inc. | 626.09M | -0.18% | 1,626,550 | - |
| 424 | CSTL | Castle Biosciences, Inc. | 626.01M | -0.29% | 219,920 | 339.92M |
| 425 | TRAX | First Tracks Biotherapeutics, Inc. | 622.13M | 1.08% | 362,951 | - |
| 426 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 618.43M | -0.39% | 344,677 | - |
| 427 | RIGL | Rigel Pharmaceuticals, Inc. | 617.97M | 1.67% | 278,419 | 299.77M |
| 428 | ACRS | Aclaris Therapeutics, Inc. | 609.63M | 1.04% | 1,675,472 | 8.37M |
| 429 | IRWD | Ironwood Pharmaceuticals, Inc. | 607.42M | 1.10% | 2,003,156 | 361.51M |
| 430 | CBIO | Crescent Biopharma, Inc. | 603.44M | 1.34% | 179,387 | 11.88M |
| 431 | DRUG | Bright Minds Biosciences Inc. | 598.77M | -2.30% | 920,517 | - |
| 432 | TLRY | Tilray Brands, Inc. | 597.01M | 0.50% | 3,777,343 | 858.28M |
| 433 | TCMD | Tactile Systems Technology, Inc. | 594.13M | 0.11% | 116,714 | 343.52M |
| 434 | IMMX | Immix Biopharma, Inc. | 590.08M | 0.06% | 970,292 | - |
| 435 | BWAY | BrainsWay Ltd. | 581.67M | -1.64% | 81,662 | 56.22M |
| 436 | ACHV | Achieve Life Sciences, Inc. | 573.35M | 1.18% | 1,941,096 | - |
| 437 | PHR | Phreesia, Inc. | 565.27M | 0.94% | 1,152,271 | 495.59M |
| 438 | TECX | Tectonic Therapeutic, Inc. | 556.64M | -2.58% | 103,596 | - |
| 439 | MDXG | MiMedx Group, Inc. | 549.61M | 2.50% | 1,075,418 | 389.42M |
| 440 | CLYM | Climb Bio, Inc. | 549.34M | 0.52% | 1,174,624 | - |
| 441 | GYRE | Gyre Therapeutics, Inc. | 537.27M | -0.84% | 50,687 | 117.05M |
| 442 | DNA | Ginkgo Bioworks Holdings, Inc. | 535.66M | 3.93% | 636,303 | 151.40M |
| 443 | AQST | Aquestive Therapeutics, Inc. | 531.91M | 1.68% | 1,307,610 | 50.27M |
| 444 | EVH | Evolent Health, Inc. | 528.10M | -2.19% | 2,689,612 | 1.89B |
| 445 | XOMA | XOMA Royalty Corporation | 525.59M | 0.29% | 101,560 | 48.56M |
| 446 | FLGT | Fulgent Genetics, Inc. | 523.42M | -1.34% | 159,249 | 320.35M |
| 447 | NPCE | NeuroPace, Inc. | 523.00M | -1.92% | 191,873 | 99.53M |
| 448 | PRME | Prime Medicine, Inc. | 522.89M | 4.32% | 2,906,637 | 4.03M |
| 449 | TOI | The Oncology Institute, Inc. | 518.41M | -2.35% | 2,520,275 | 545.76M |
| 450 | CTEV | Claritev Corporation | 514.67M | -2.27% | 84,346 | 978.76M |
| 451 | ALT | Altimmune, Inc. | 512.44M | 0.96% | 3,503,759 | 36.00K |
| 452 | VRXA | VERAXA Biotech AG | 509.89M | 1.10% | 59,014 | - |
| 453 | SRTA | Strata Critical Medical, Inc. | 509.21M | 8.38% | 1,887,800 | 228.58M |
| 454 | EIKN | Eikon Therapeutics, Inc. | 508.36M | 7.31% | 303,974 | - |
| 455 | CTKB | Cytek Biosciences, Inc. | 506.88M | -0.88% | 1,551,444 | 204.17M |
| 456 | VALN | Valneva SE | 504.32M | 0.65% | 14,572 | 180.25M |
| 457 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 458 | CERS | Cerus Corporation | 503.93M | -1.76% | 2,117,606 | 216.56M |
| 459 | PROK | ProKidney Corp. | 502.93M | 1.52% | 568,658 | 889.00K |
| 460 | STRO | Sutro Biopharma, Inc. | 499.60M | 4.69% | 177,699 | 99.61M |
| 461 | AGMB | AgomAb Therapeutics NV | 498.39M | 5.31% | 158,230 | - |
| 462 | ANGO | AngioDynamics, Inc. | 498.10M | -1.24% | 266,210 | 313.73M |
| 463 | KYTX | Kyverna Therapeutics, Inc. | 492.72M | 1.06% | 580,963 | - |
| 464 | CABA | Cabaletta Bio, Inc. | 489.98M | -0.17% | 3,229,886 | - |
| 465 | ARVN | Arvinas, Inc. | 481.97M | -1.45% | 574,475 | 89.40M |
| 466 | FDMT | 4D Molecular Therapeutics, Inc. | 480.94M | 4.19% | 1,064,415 | 88.24M |
| 467 | CTNM | Contineum Therapeutics, Inc. | 478.73M | 7.79% | 430,241 | - |
| 468 | NGNE | Neurogene Inc. | 470.42M | 2.30% | 101,027 | 925.00K |
| 469 | KIDS | OrthoPediatrics Corp. | 465.41M | 1.68% | 160,613 | 243.30M |
| 470 | ASMB | Assembly Biosciences, Inc. | 461.05M | 1.33% | 158,687 | 71.10M |
| 471 | RZLT | Rezolute, Inc. | 452.86M | 8.38% | 2,393,791 | - |
| 472 | EOLS | Evolus, Inc. | 444.19M | 0.22% | 903,181 | 301.79M |
| 473 | ANL | Adlai Nortye Ltd. | 443.60M | 7.46% | 144,280 | 5.00M |
| 474 | ARTV | Artiva Biotherapeutics, Inc. | 441.67M | 6.44% | 765,099 | 251.00K |
| 475 | FBRX | Forte Biosciences, Inc. | 440.82M | 2.73% | 124,992 | - |
| 476 | VREX | Varex Imaging Corporation | 440.01M | -5.43% | 262,376 | 857.50M |
| 477 | PRLD | Prelude Therapeutics Incorporated | 439.36M | -1.34% | 315,174 | 16.72M |
| 478 | WEAV | Weave Communications, Inc. | 433.23M | -1.36% | 1,172,133 | 248.72M |
| 479 | INDP | Indaptus Therapeutics, Inc. | 430.89M | 6.28% | 358,250 | - |
| 480 | KMDA | Kamada Ltd. | 429.92M | 0.40% | 18,169 | 181.68M |
| 481 | EBS | Emergent BioSolutions Inc. | 428.25M | -0.24% | 688,681 | 676.80M |
| 482 | PRTA | Prothena Corporation plc | 424.06M | -1.82% | 526,772 | 57.94M |
| 483 | CCCC | C4 Therapeutics, Inc. | 422.37M | -2.05% | 1,551,637 | 34.86M |
| 484 | OVID | Ovid Therapeutics Inc. | 420.87M | -1.96% | 1,842,845 | 7.12M |
| 485 | IPSC | Century Therapeutics, Inc. | 417.52M | 2.89% | 1,078,408 | 109.16M |
| 486 | CYH | Community Health Systems, Inc. | 416.52M | -1.44% | 903,801 | 12.29B |
| 487 | MNPR | Monopar Therapeutics Inc. | 411.77M | 2.84% | 154,175 | - |
| 488 | NRC | NRC Health | 411.75M | -2.77% | 109,664 | 138.64M |
| 489 | OCGN | Ocugen, Inc. | 411.30M | 0.41% | 5,925,952 | 4.47M |
| 490 | VTVT | vTv Therapeutics Inc. | 408.89M | 0.56% | 51,382 | 36.84M |
| 491 | PACB | Pacific Biosciences of California, Inc. | 408.44M | 0.38% | 5,280,407 | 160.03M |
| 492 | CCRN | Cross Country Healthcare, Inc. | 408.22M | -0.04% | 255,449 | 1.00B |
| 493 | DCTH | Delcath Systems, Inc. | 406.67M | 0.51% | 447,558 | 90.44M |
| 494 | MYGN | Myriad Genetics, Inc. | 406.13M | -0.69% | 1,128,269 | 829.00M |
| 495 | CLPT | ClearPoint Neuro, Inc. | 405.16M | 0.52% | 324,766 | 40.61M |
| 496 | SGMT | Sagimet Biosciences Inc. | 400.77M | 0.15% | 574,263 | - |
| 497 | AUTL | Autolus Therapeutics plc | 400.55M | -3.53% | 1,274,005 | 92.62M |
| 498 | VMD | Viemed Healthcare, Inc. | 398.89M | -0.43% | 199,109 | 286.57M |
| 499 | EPRX | Eupraxia Pharmaceuticals Inc. | 395.37M | 3.31% | 249,877 | - |
| 500 | BNTC | Benitec Biopharma Inc. | 393.70M | 2.50% | 71,076 | - |